Treatment of Kala-Azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: A retrospective comparison with 30-day sodium stibogluconate monotherapy

American Journal of Tropical Medicine and Hygiene

Volumn 77, Issue 1, 2007, Pages 89-94

  Melaku, Yosef ^b   Collin, Simon M ^a   Keus, Kees ^b   Gatluak, Francis ^b   Ritmeijer, Koert ^b   Davidson, Robert N ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MÉDECINS SANS FRONTIÈRES   (Switzerland)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; PAROMOMYCIN; STIBOGLUCONATE SODIUM; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT;

ADOLESCENT; ARTICLE; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DEATH; FEMALE; HUMAN; INFANT; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEWBORN; RETROSPECTIVE STUDY; RISK; SUDAN; SURVIVAL; THERAPY EFFECT; DRUG ADMINISTRATION; DRUG COMBINATION; MEDICAL RECORD; MORTALITY; PRESCHOOL CHILD; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

NASO HEXACANTHUS;

ADOLESCENT; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEISHMANIASIS, VISCERAL; MALE; MEDICAL RECORDS; PAROMOMYCIN; RETROSPECTIVE STUDIES; SUDAN; TREATMENT OUTCOME;

EID: 34548707878     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2007.77.89     Document Type: Article

References (13)

1. Zijlstra EE, el-Hassan AM, 2001. Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg 95 (Suppl 1): S27-S58.
2. Seaman J, Mercer AJ, Sondorp E, 1996. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25: 862-871.
3. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD, 2002. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2: 494-501.
4. Ritmeijer K, Davidson RN, 2003. Royal Society of Tropical Medicine and Hygiene joint meeting with Medecins sans Frontieres at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Medecins sans Frontieres interventions against kala-azar in the Sudan. 1989-2003. Trans R Soc Trop Med Hyg 97: 609-613.
5. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson AD, Davidson RN, 1993. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis 168: 715-720.
6. Chunge CN, Owate J, Pamba HO, Donno L, 1990. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg 84: 221-225.
7. Scott JA, Davidson RN, Moody AH, Grant HR, Felmingham D, Scott GM, Olliaro P, Bryceson AD, 1992. Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 86: 617-619.
8. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, Kumar M, Verma BB, 1992. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg 86: 615-616.
9. Thakur CP, Bhowmick S, Dolfi L, Olliaro P, 1995. Aminosidine plus sodium stibogluconate for the treatment of Indian kalaazar: a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg 89: 219-223.
10. Thakur CP, Kanyok TP, Pandey AK, Sinha GP, Zaniewski AE, Houlihan HH, Olliaro P, 2000. A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg 94: 429-431.
11. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL, 1996. Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 124: 664-672.
12. World Health Organization, 1996. Manual on Visceral Leishma niasis Control. Geneva: World Health Organization.
13. Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, Kipngetich S, Davies C, 2004. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin Infect Dis 38: 612-619.